Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charis Pericleous

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Cell and Developmental Biology|September 9, 2021
Activation and Contraction of Human "Vascular" Smooth Muscle Cells Grown From Circulating Blood ProgenitorsBlerina Ahmetaj-Shala, Isra Marei, Ryota Kawai, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 7, 2011
Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparinTamara Y Carroll, Melissa J Mulla, Christina S Han, et al.
Frontiers in Immunology|November 12, 2020
Identification of a Novel HIF-1α-α<sub>M</sub>β<sub>2</sub> Integrin-NET Axis in Fibrotic Interstitial Lung DiseaseAkif A Khawaja, Deborah L W Chong, Jagdeep Sahota, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2025
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodiesHannah F Bradford, Christophe J Lalaurie, Jayesh Gor, et al.
Frontiers in Immunology|November 9, 2018
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid SyndromeThomas C R McDonnell, Rohan Willis, Charis Pericleous, et al.
Rheumatology (Oxford, England)|October 3, 2014
Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosisCharis Pericleous, Patricia Ruiz-Limón, Zurina Romay-Penabad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2025
Proteomic Profiling of the Large-Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal RemodelingRobert T Maughan, Erin Macdonald-Dunlop, Lubna Haroon-Rashid, et al.
Arthritis and Rheumatism|May 28, 2011
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein IYiannis Ioannou, Jing-Yun Zhang, Miao Qi, et al.
Blood|January 26, 2026
Von Willebrand Factor Deficiency Impairs Angiogenesis via Angiopoietin-2: Relevance for Gut AngiodysplasiaAdela Constantinescu-Bercu, Koval E Smith, Shuo Yi Wong, et al.
Circulation Research|September 5, 2024
EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites Through Endothelial Fatty Acid UptakeDaniela Pirri, Siyu Tian, Blanca Tardajos-Ayllon, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Cell and Developmental Biology|September 9, 2021
Activation and Contraction of Human "Vascular" Smooth Muscle Cells Grown From Circulating Blood ProgenitorsBlerina Ahmetaj-Shala, Isra Marei, Ryota Kawai, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 7, 2011
Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparinTamara Y Carroll, Melissa J Mulla, Christina S Han, et al.
Frontiers in Immunology|November 12, 2020
Identification of a Novel HIF-1α-α<sub>M</sub>β<sub>2</sub> Integrin-NET Axis in Fibrotic Interstitial Lung DiseaseAkif A Khawaja, Deborah L W Chong, Jagdeep Sahota, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2025
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodiesHannah F Bradford, Christophe J Lalaurie, Jayesh Gor, et al.
Frontiers in Immunology|November 9, 2018
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid SyndromeThomas C R McDonnell, Rohan Willis, Charis Pericleous, et al.
Rheumatology (Oxford, England)|October 3, 2014
Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosisCharis Pericleous, Patricia Ruiz-Limón, Zurina Romay-Penabad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2025
Proteomic Profiling of the Large-Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal RemodelingRobert T Maughan, Erin Macdonald-Dunlop, Lubna Haroon-Rashid, et al.
Arthritis and Rheumatism|May 28, 2011
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein IYiannis Ioannou, Jing-Yun Zhang, Miao Qi, et al.
Blood|January 26, 2026
Von Willebrand Factor Deficiency Impairs Angiogenesis via Angiopoietin-2: Relevance for Gut AngiodysplasiaAdela Constantinescu-Bercu, Koval E Smith, Shuo Yi Wong, et al.
Circulation Research|September 5, 2024
EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites Through Endothelial Fatty Acid UptakeDaniela Pirri, Siyu Tian, Blanca Tardajos-Ayllon, et al.
Pageof 6